Ephrin receptor 3D structures
From Proteopedia
(Difference between revisions)
| Line 11: | Line 11: | ||
**[[1x5a]] - hEPHR A1 fn3 domain – NMR<BR | **[[1x5a]] - hEPHR A1 fn3 domain – NMR<BR | ||
| - | *Ephrin A2 receptor; domains – LBD 28-200; ectodomain 27-435; kinase 596-900; SAM fragment 945-969 | + | *Ephrin A2 receptor; domains – LBD 28-200; CRD 201-326; ectodomain 27-435; C-terminal FN3 436-529; kinase 596-900; SAM fragment 945-969 |
**[[3hpn]], [[3c8x]] - hEPHR A2 LBD<BR /> | **[[3hpn]], [[3c8x]] - hEPHR A2 LBD<BR /> | ||
**[[2x10]], [[3fl7]] - hEPHR A2 ectodomain<BR /> | **[[2x10]], [[3fl7]] - hEPHR A2 ectodomain<BR /> | ||
**[[2k9y]], [[2e8n]] - hEPHR A2 transmembrane domain – NMR<BR /> | **[[2k9y]], [[2e8n]] - hEPHR A2 transmembrane domain – NMR<BR /> | ||
| - | **[[1mqb]], [[4p2k]], [[4pdo]], [[4trl]], [[5ek7]], [[5i9u]] - hEPHR A2 kinase domain<BR /> | + | **[[1mqb]], [[4p2k]], [[4pdo]], [[4trl]], [[5ek7]], [[5i9u]], [[8xpv]] - hEPHR A2 kinase domain<BR /> |
**[[7kja]] - hEPHR A2 kinase+SAM domains<br /> | **[[7kja]] - hEPHR A2 kinase+SAM domains<br /> | ||
**[[7kjb]], [[7kjc]] - hEPHR A2 kinase+SAM domains (mutant)<br /> | **[[7kjb]], [[7kjc]] - hEPHR A2 kinase+SAM domains (mutant)<br /> | ||
| Line 31: | Line 31: | ||
**[[5nz9]] - hEPHR A2 SAM fragment - NMR<br /> | **[[5nz9]] - hEPHR A2 SAM fragment - NMR<br /> | ||
**[[6f7m]], [[6f7n]] - hEPHR A2 SAM fragment (mutant) - NMR<br /> | **[[6f7m]], [[6f7n]] - hEPHR A2 SAM fragment (mutant) - NMR<br /> | ||
| - | **[[5i9v]], [[5i9w]], [[5njz]], [[5nk0]], [[5nk1]], [[5nk2]], [[5nk3]], [[5nk4]], [[5nk5]], [[5nk6]], [[5nk7]], [[5nk8]], [[5nk9]], [[5nka]], [[5nkb]], [[5nkc]], [[5nkd]], [[5nke]], [[5nkf]], [[5nkg]], [[5nkh]], [[5nki]], [[6hes]], [[6het]], [[6heu]], [[6hev]], [[6hew]], [[6hex]], [[6hey]], [[6q7b]], [[6q7c]], [[6q7d]], [[6q7e]], [[6q7f]], [[6q7g]], [[8bin]], [[8bio]], [[8bk0]] - hEPHR A2 kinase domain + inhibitor<br /> | + | **[[5i9v]], [[5i9w]], [[5njz]], [[5nk0]], [[5nk1]], [[5nk2]], [[5nk3]], [[5nk4]], [[5nk5]], [[5nk6]], [[5nk7]], [[5nk8]], [[5nk9]], [[5nka]], [[5nkb]], [[5nkc]], [[5nkd]], [[5nke]], [[5nkf]], [[5nkg]], [[5nkh]], [[5nki]], [[6hes]], [[6het]], [[6heu]], [[6hev]], [[6hew]], [[6hex]], [[6hey]], [[6q7b]], [[6q7c]], [[6q7d]], [[6q7e]], [[6q7f]], [[6q7g]], [[8bin]], [[8bio]], [[8bk0]], [[8bm8]], [[8boc]], [[8bod]], [[8bof]], [[8bog]], [[8boh]], [[8boi]], [[8bok]], [[8bom]], [[8qqy]] - hEPHR A2 kinase domain + inhibitor<br /> |
**[[6fnf]], [[6fng]], [[6fnh]] – hEPHR A2 kinase domain + pyrimidine derivative<br /> | **[[6fnf]], [[6fng]], [[6fnh]] – hEPHR A2 kinase domain + pyrimidine derivative<br /> | ||
**[[5i9x]], [[5i9y]], [[5i9z]], [[5ia0]], [[5ia1]], [[5ia2]], [[5ia3]], [[5ia4]], [[5ia5]] - hEPHR A2 kinase domain + kinase drug<br /> | **[[5i9x]], [[5i9y]], [[5i9z]], [[5ia0]], [[5ia1]], [[5ia2]], [[5ia3]], [[5ia4]], [[5ia5]] - hEPHR A2 kinase domain + kinase drug<br /> | ||
| + | **[[8trs]], [[8trt]] - hEPHR A2 CRD domain + antibody<br /> | ||
| + | **[[8trv]], [[8tv1]], [[8tv5]] - hEPHR A2 LBD+CRD domains + antibody<br /> | ||
| + | **[[8t9b]] - hEPHR A2 C-terminal FN3 domain + antibody<br /> | ||
*Ephrin A3 receptor | *Ephrin A3 receptor | ||
| Line 73: | Line 76: | ||
**[[1shx]] - mEPHR A5 <br /> | **[[1shx]] - mEPHR A5 <br /> | ||
**[[5zrz]] – mEPHR SAM domain + SAMD5<br /> | **[[5zrz]] – mEPHR SAM domain + SAMD5<br /> | ||
| + | |||
| + | *Ephrin A6 receptor | ||
| + | |||
| + | **[[8z8w]] – mEPHR A6 C-terminal/caskin-1<BR /> | ||
*Ephrin A7 receptor | *Ephrin A7 receptor | ||
| Line 87: | Line 94: | ||
**[[1x5l]] – hEPHR A8 fn3 domain – NMR<BR /> | **[[1x5l]] – hEPHR A8 fn3 domain – NMR<BR /> | ||
**[[1ucv]] - hEPHR A8 SAM – NMR<BR /> | **[[1ucv]] - hEPHR A8 SAM – NMR<BR /> | ||
| + | **[[8j1i]] - mEPHR A8 SAM <BR /> | ||
*Ephrin B1 receptor | *Ephrin B1 receptor | ||
Current revision
3D Structures of ephrin receptors
Updated on 27-May-2025
